NEW YORK , July 17, 2023 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc. . Such investors are advised to contact Robert S..
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ: ETON). Such.
Eton Pharmaceuticals (NASDAQ:ETON – Free Report) had its price objective cut by HC Wainwright from $10.00 to $9.00 in a report released on Monday morning, FlyOnTheWall reports. HC Wainwright also issued estimates for Eton Pharmaceuticals’ FY2023 earnings at ($0.31) EPS, Q1 2024 earnings at ($0.03) EPS, Q2 2024 earnings at $0.02 EPS, Q3 2024 earnings […]
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Free Report) – Equities researchers at HC Wainwright dropped their Q2 2024 earnings estimates for shares of Eton Pharmaceuticals in a note issued to investors on Monday, July 3rd. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings per share of $0.02 for the quarter, down […]